Human PON1, a biomarker of risk of disease and exposure - Wikidata - wikimedia - TriplyDB

Human PON1, a biomarker of risk of disease and exposure

Human PON1, a biomarker of risk of disease and exposure

http://www.wikidata.org/entity/Q28386131

about

Paraoxonase-1 and early-life environmental exposures Quorum quenching revisited--from signal decays to signalling confusion Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.Association of organophosphate pesticide exposure and paraoxonase with birth outcome in Mexican-American women PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos Paraoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data.Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy males Dialkyl phosphates as biomarkers of organophosphates: the current divide between epidemiology and clinical toxicology.Serum paraoxonase 1 (PON1) measurement: an update.Regulation of paraoxonase 1 (PON1) in PCB 126-exposed male Sprague Dawley rats Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases.Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.Long term stability of paraoxonase-1 and high-density lipoprotein in human serum.Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.Dietary antioxidants (selenium and N-acetylcysteine) modulate paraoxonase 1 (PON1) in PCB 126-exposed rats.Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.Nosocomial infections after severe trauma are associated with lower apolipoproteins B and AII.Paraoxonase 1 in chronic kidney failure Paraoxonase 1 in neurological disorders.Autism spectrum disorder: an omics perspective.Linking the Epigenome with Exposure Effects and Susceptibility: The Epigenetic Seed and Soil Model.Metals and Paraoxonases.Solubilization and humanization of paraoxonase-1 PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans.Potential association of paraoxonase-1, type 2 diabetes mellitus, and periodontitis.Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.Molecular detection of M. tuberculosis and M. bovis and hematological and biochemical analyses in agricultural sprayers exposed to pesticides: A cross-sectional study in Punjab, Pakistan during 2014-2016.Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study.Amniotic fluid paraoxonase-1 activity, thyroid hormone concentration and oxidant status in neural tube defects.Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.Joint Effects of PON1 Polymorphisms and Vegetable Intake on Ischemic Stroke: A Family-Based Case Control Study.Toxic effects of methamidophos on paraoxonase 1 activity and on rat kidney and liver and ameliorating effects of alpha-tocopherol.Determination of the genotype and phenotype of serum paraoxonase 1 (PON1) status in a group of agricultural and nonagricultural workers in the Coquimbo Region, Chile.Effect of adipose tissue-derived mesenchymal stem cell treatment on oxidative stress and inflammatory response following Escherichia coli lipopolysaccharide Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide Sepsis and Oxidative Stress in the Newborn: From Pathogenesis to Novel Therapeutic Targets Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives

P2860

Q26744234-88696EB6-5F98-4D40-A518-48675C333B31 Q27004217-039E7E41-2570-49D1-B258-4BCAB2B99479 Q28383254-C6B429D7-B715-4997-9004-5815BB935A66 Q28391420-F218A63D-FCB6-4328-87FC-D82C4D9EC765 Q28391665-9913519D-C625-4F6A-9D1A-F80AA36DDB7B Q30829280-B35BA266-C42C-4110-ACC2-78067C018111 Q33878870-16F4D18C-3621-4AED-A55D-A07ADC8B7BC6 Q33898495-E833FED5-77B9-42F1-BD26-EA3B38B4BE01 Q34231908-D20DE79B-94CA-4D2E-A099-CDBCCC28BEFF Q35130601-2CE8150B-8123-4FFF-9AD7-FC61358D5883 Q35783249-BC8FFB21-6D00-4E0C-8042-1361E9F0EB5C Q35861492-B646D976-5927-40D6-9E87-080072748B11 Q35999630-B89D9573-9BB0-4DDB-BDA6-DD442A911533 Q36198367-940265AD-A22A-488D-B17A-C0F0783AC18C Q36658423-56D83309-A358-45F7-AB17-A07CFBF225CF Q37161117-D43B3DEB-8845-466A-A966-6DF3E7BD53A0 Q37391305-3C6EF9B7-2007-4FF6-AC42-EA1C47FA2334 Q37463147-22F85068-F1C0-4502-A0EE-D94BB2BDB454 Q37555546-A3FAC334-1A77-466C-ADDE-CCAE6BD4D686 Q38004498-531ED33B-5F0D-4878-949B-02F30CB769FD Q38162323-F4C43F4C-D59E-4469-B710-F566BF55307A Q38259780-3C6020CE-6758-41A0-8B00-4E818304E04A Q39042158-FB2811F2-EA76-473A-8C40-FA01B332C4FF Q40058771-7D054B9B-0700-4245-B7E6-058CEC7F941E Q42203958-F5418A75-D7AE-4E17-91A8-2C728A3D58D1 Q43107935-8ABC05DF-5403-45A3-97BD-F34789EC5B88 Q43467302-A5A100A6-B1FB-4A38-A1B1-C01BB9B178CD Q46976986-160F84DB-B73C-41FA-A3BF-4A9DC41DECB6 Q47581550-D2EB996A-E957-4519-92F6-76CAAD8B972D Q47693302-B2849A06-8284-4EF8-99C7-05249892AEF3 Q47764463-F53B9900-F038-4173-9EB4-6483828C65E1 Q48252102-F1B6495D-BF7C-4875-928A-D74FCFC8F00C Q49476953-B5797A5B-0F47-4288-8473-A217371DD843 Q52786567-9EBBAE53-8321-4FB4-8FED-DA48ED6EEE5F Q52794280-145E845B-3B1B-455E-816F-6636CC22B4B1 Q57729861-98BA5493-3A0C-431B-B284-15B337B0D04C Q57729876-571490A4-1DFC-4736-817F-7613C33A4157 Q58802979-35617FE7-2C2D-44CE-8823-CFC0BC44F26B Q59101037-AB998359-3FFB-49B2-A575-E68870D99302

P2860

Human PON1, a biomarker of risk of disease and exposure

http://www.wikidata.org/entity/Q28386131

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Human PON1, a biomarker of risk of disease and exposure

@ast

Human PON1, a biomarker of risk of disease and exposure

@en

Human PON1, a biomarker of risk of disease and exposure

@nl

type

label

Human PON1, a biomarker of risk of disease and exposure

@ast

Human PON1, a biomarker of risk of disease and exposure

@en

Human PON1, a biomarker of risk of disease and exposure

@nl

prefLabel

Human PON1, a biomarker of risk of disease and exposure

@ast

Human PON1, a biomarker of risk of disease and exposure

@en

Human PON1, a biomarker of risk of disease and exposure

@nl

P1433

Q28386131-4A277DC1-90D6-4331-894B-E60343027993

P1476

Q28386131-6862483A-6748-4CF3-A440-171EEE5CD9B9

P2093

Q28386131-05CA5FA9-0E2F-44EA-B120-000501AD37D1

Q28386131-21839F17-1F74-437F-9AE8-4DAAB0524C9C

Q28386131-23C655E6-B72B-4E2A-BDBA-D18EAD8161F9

Q28386131-346F0404-B1EA-4EB8-BEB6-BB2BF0365A19

Q28386131-68DC4F97-B8BA-4F85-8AC6-3A645F765FB5

Q28386131-7887CE34-503B-4D6A-B90B-E50F5239DB40

Q28386131-79BF5C7B-4BAF-4B79-9787-82721DB12F67

Q28386131-8D84DABC-AB70-4D77-8120-F7177EAE8DFC

Q28386131-8E0764CF-643B-4645-8DFE-8A5E6C8DE83F

Q28386131-BEFD0694-F95A-4FDF-B562-DA8689516978

P2860

Q28386131-03CF021F-A3E7-4563-BBC1-DAD888E5D57F

Q28386131-0664A6A0-F512-448A-943F-9AE9611ABCEA

Q28386131-110BCFA1-0B5F-43D8-A97D-5B8BF6813DE4

Q28386131-11DBA431-37AE-4849-A801-44F1A3501571

Q28386131-12C13E5F-6B6F-42FD-A985-2A076A2C2EE1

Q28386131-1A330161-F546-4392-BE49-39EE7007D0D6

Q28386131-1AAE85B8-BAE6-4A0F-B2CD-249C96E7E870

Q28386131-22D1A408-6B67-479D-9766-D811EC059F6D

Q28386131-2322C8ED-47A4-496D-BF90-F65B42A73FBA

Q28386131-2B22FE32-D655-4788-B8FD-595DD8660EF8

P304

Q28386131-5362AE77-45D4-4E23-A2DA-9C45EE44B241

P31

Q28386131-B1C5F986-080E-4D92-BB0E-CAE6B0A7AAE8

P356

Q28386131-265BC7D9-921B-4C5B-AC66-DD36E9AA008D

P407

Q28386131-FB7E8B3A-FA2D-4809-A748-2B2C33E66581

P433

Q28386131-8862BA6F-347E-4486-A033-36A7A72E9C14

P478

Q28386131-E7AA8F4A-382F-44A3-A004-79E4E9BFD7EB

P577

Q28386131-C42F14BA-187E-42AE-B7C0-90A404D1B2A7

P5875

Q28386131-F7D7C35C-212D-4FEE-AD80-56B8CF08BE37

P698

Q28386131-7C614231-9784-406A-AC0F-B48F2D2A8568

P921

Q28386131-469CE486-A5B1-4742-B63B-233C4E496FD1

P932

Q28386131-4E85C305-6F44-45D9-B63C-55032B2D9DAD

P356

J.CBI.2010.03.033

P1433

Chemico-biological Interactions

P1476

Human PON1, a biomarker of risk of disease and exposure

@en

P2093

A Griffith

http://www.w3.org/2001/XMLSchema#string

A Samii

http://www.w3.org/2001/XMLSchema#string

C E Furlong

http://www.w3.org/2001/XMLSchema#string

C P Zabetian

http://www.w3.org/2001/XMLSchema#string

D Yearout

http://www.w3.org/2001/XMLSchema#string

G P Jarvik

http://www.w3.org/2001/XMLSchema#string

H Checkoway

http://www.w3.org/2001/XMLSchema#string

J Marsillach

http://www.w3.org/2001/XMLSchema#string

J W Roberts

http://www.w3.org/2001/XMLSchema#string

L G Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-exposed agricultural pesticide handlers

Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats.

Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence

Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination

The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis

Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism

No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population

Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1

P304

355-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CBI.2010.03.033

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42588278

http://www.w3.org/2001/XMLSchema#string

P698

20338154

http://www.w3.org/2001/XMLSchema#string

P921

P932

3035622

http://www.w3.org/2001/XMLSchema#string